In addition to CRP and albumin, different scoring systems, including variable inflammatory markers (like white blood cell count, procalcitonin, NT-pro-BNP, and troponin) and clinical features (like hypertension, CRF, and AF) were examined to determine acute and long-term negative outcomes in patients with HF [21,22,23,24]. This evidence concerns the gene NPPB and atrial fibrillation.